Schedule of earnings conference call for Q1 FY27

July 24, 2026 To To The Secretary The Secretary National Stock Exchange of India Limited BSE Limited Exchange Plaza, Phiroze Jeejeebhoy Towers, Bandra-Kurla Complex, Bandra (East) Dalal Street Mumbai – 400051 Mumbai – 400001 Trading Symbol: DIVISLAB Scrip Code: 532488 Dear Sir / Madam, Sub: Schedule of earnings conference call for Q1 FY27 Ref: Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we are enclosing herewith the schedule of earnings conference call for the quarter ended June 30, 2026, to be held on August 01, 2026. This is for your information and records. Thanking You, Yours faithfully, For Divi's Laboratories Limited M. Satish Choudhury Company Secretary & Compliance Officer ANNOUNCEMENT Divi’s Labs to release unaudited financial results for the quarter ended June 30, 2026 (Q1 FY27) on August 01, 2026 Schedule of earnings conference call: August 01, 2026, at 14:00 hrs (IST) Post release of unaudited financial results for the quarter ended June 30, 2026, the Management of the Company will host an earnings conference call on August 01, 2026, at 14:00 hrs (IST) to discuss the Company’s financial performance. A transcript of the conference call will be available at the Company’s website: www.divislabs.com. Earnings Conference call Dial-in Information: Option 1: Express Join with DiamondPass™ Pre-register and join without waiting for the operator: Click on the link for DiamondPass Registration. https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=5267888&linkSecurityString=2cef0b9d90 Option 2: Join through below Dial-In Numbers Universal Dial-In: +91 22 6280 1526 +91 22 7115 8341 To participate in the audio call, please dial the numbers provided above about five minutes ahead of the scheduled start time. The operator will provide instructions on asking questions before the call. For further information, please contact: Investor Relations: Mobile: +91 91542 18881 Phone: +91 40 66966352